Commercial Services and Supplies
Company Overview of Biotechnology Industry Organization
Biotechnology Industry Organization (BIO) is an association of more than 1000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations. The organization provides biotechnology information, advocacy, and business development services to member companies. It offers services that include research and development of healthcare, agricultural, industrial, and environmental biotechnology products such as pharmaceuticals, drug discovery and development, genomics, and proteomics. BIO was created through the merger of the Industrial Biotechnology Association and the Association of Biotechnology Companies. The organization was founded in 1993 and is based i...
1201 Maryland Avenue SW
Washington, DC 20024
Founded in 1993
Key Executives for Biotechnology Industry Organization
Chief Executive Officer and President
Executive Vice President of International Affairs
Executive Vice President for Emerging Companies and Business Development
Chairman of Industrial & Environmental Section and Director
Compensation as of Fiscal Year 2015.
Biotechnology Industry Organization Key Developments
Biotechnology Industry Organization Appoints Joel S. Marcus to its Board of Directors and Emerging Companies Section Governing Board
Jul 13 15
Alexandria Real Estate Equities Inc. announced that Chairman, Chief Executive Officer, and Founder Joel S. Marcus has been appointed to the Biotechnology Industry Organization (BIO) Board of Directors for the 2015-2016 term, and will also serve on the Emerging Companies Section Governing Board. Marcus brings extensive expertise and support to the BIO Board and to emerging companies as they develop and navigate policy issues. As a BIO board member, Mr. Marcus will work to carry out BIO's mission efficiently and effectively to help prevent illness, save lives and improve the quality of life for patients.
Biotechnology Industry Organization Appoints Nancy Simonian to Emerging Companies Section Governing Board
Jul 6 15
Syros Pharmaceuticals announced that Chief Executive Officer Nancy Simonian, M.D., has been appointed to the Biotechnology Industry Organization’s (BIO) Emerging Companies Section Governing Board. Dr. Simonian will join with other industry leaders to help shape a policy and legislative agenda for BIO that promotes the needs of emerging companies.
Biotechnology Industry Organization Appoints James Sapirstein BIO's ECS Board of Directors and BioNJ's Board of Trustees
Jun 15 15
ContraVir Pharmaceuticals Inc. announced the appointment of ContraVir CEO James Sapirstein to the Biotechnology Industry Organization Emerging Companies Section Governing Board (ECSGB) and the Capital Formation Committee. Additionally, Mr. Sapirstein has been appointed to the Board of Trustees of BioNJ. James Sapirstein brings more than 30 years of experience in the pharmaceutical industry to BIO and BioNJ and continues to advocate support for the life sciences industry both within ContraVir's home state and across the country.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries